13-36965643-CTG-C
Position:
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PVS1PM2PP5
The NM_013338.5(ALG5):c.703_704del(p.Gln235ValfsTer21) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Consequence
ALG5
NM_013338.5 frameshift
NM_013338.5 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 9.97
Genes affected
ALG5 (HGNC:20266): (ALG5 dolichyl-phosphate beta-glucosyltransferase) This gene encodes a member of the glycosyltransferase 2 family. The encoded protein participates in glucosylation of the oligomannose core in N-linked glycosylation of proteins. The addition of glucose residues to the oligomannose core is necessary to ensure substrate recognition, and therefore, effectual transfer of the oligomannose core to the nascent glycoproteins. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 11 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 13-36965643-CTG-C is Pathogenic according to our data. Variant chr13-36965643-CTG-C is described in ClinVar as [Pathogenic]. Clinvar id is 1708161.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr13-36965643-CTG-C is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ALG5 | NM_013338.5 | c.703_704del | p.Gln235ValfsTer21 | frameshift_variant | 8/10 | ENST00000239891.4 | |
ALG5 | NM_001142364.1 | c.613_614del | p.Gln205ValfsTer21 | frameshift_variant | 7/9 | ||
ALG5 | XM_047430283.1 | c.514_515del | p.Gln172ValfsTer21 | frameshift_variant | 6/8 | ||
ALG5 | XR_007063678.1 | n.879_880del | non_coding_transcript_exon_variant | 9/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ALG5 | ENST00000239891.4 | c.703_704del | p.Gln235ValfsTer21 | frameshift_variant | 8/10 | 1 | NM_013338.5 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Polycystic kidney disease 7 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 04, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.